In this article, we will discuss Alitretinoin (Clinical Studies-1). So, let’s get started.
- Clinical Studies
- Alitretinoin gel is not a systemic therapy; it therefore cannot treat visceral Kaposi’s sarcoma (KS) nor prevent the development of new KS lesions where it has not been applied. Visceral KS disease was not monitored in these trials, and the appearance of new KS lesions was not considered part of the response assessment in clinical trials.